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Background: Enediyne chromoproteins are potent 
antitumor antibiotic agents. They consist of a labile 
nine-membered enediyne chromophore non-covalently 
associated with a stabilizing acidic polypeptide. Studies 
in vitro on three members of this superfamily of natural 
products - kedarcidin, maduropeptin and neocarzino- 
statin - demonstrated that their chromophores cleave 
DNA at sites specific to each chromophore. Recently, 
we showed that these chromoproteins possess prote- 
olytic activity against histones ia vitro, with histone HI 
as a preferred substrate. Based on these results, we specu- 
lated that this selective proteolytic activity may be 
important in vim in the delivery of the enediynes intact 
to the DNA in chromatin. 
Results: We show here that each chromoprotein gener- 
ates a unique set of Hl fragments as revealed by gel 
analyses of the Hl cleavage reaction products.To probe 
the observed cleavage specificity, we synthesized a 24- 
amino-acid peptide representing a basic region of 
histone Hl. This model peptide was incubated individu- 
ally with similar concentrations of the kedarcidin, neo- 
carzinostatin and maduropeptin chromoproteins as well 
as the kedarcidin apoprotein.The reaction products were 
analyzed by electrospray liquid chromatography/mass 
spectrometry. Our results indicate that all proteins cleave 
the peptide at selected backbone amides, and that these 
sites vary according to the chromoprotein used. 
Moreover, the kedarcidin apoprotein appears to be less 
specific than the kedarcidin chromoprotein complex. 
Conclusions: The small size, unique architecture and 
very acidic nature of the enediyne chromoproteins are 
highly unusual. These natural products exhibit the dual 
functionalities of specific DNA cleavage and selective 
proteolytic activity. This observation adds to the fasci- 
nating properties of these molecules and suggests that it 
is possible not only to design small moieties to cleave 
DNA but also to conceive of small proteins to deliver 
these moieties intact to defined areas of chromatin. 
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Introduction 
Enediyne chromoproteins are unusually potent anti- 
tumor antibiotics with a unique molecular architecture. 
They consist of a labile nine-membered enediyne-con- 
taining chromophore, non-covalently associated with a 
highly acidic, stabilizing polypeptide. These chromopro- 
teins include kedarcidin (KDC), neocarzinostatin 
(NCS), macromomycin, actinoxanthin, maduropeptin 
(MDP) and Cl027 [l-16]. A comparison of the amino- 
acid sequences (Hans Marquardt, personal communica- 
tion) shows that KDC shares 38.7 % identity with NCS 
in a Ill-residue overlap (four gaps), 36.0 % identity 
with macromomycin in a ill-residue overlap (two 
gaps) and 40.2 % identity with actinoxanthin in a 107- 
residue overlap (five gaps).The amino-acid sequences of 
MDP and Cl027 have not yet been disclosed. 
Mechanistic studies have been performed primarily on 
the chromophores of NCS, KDC, Cl027 and MDP 
[l-20]. These chromophores were shown to cleave 
DNA in vitro at sites specific to each chromophore. 
This DNA damage was proposed to be responsible for 
the potent biological activities of the holoantibiotics. 
Furthermore, it was suggested that the apoprotein 
component of the complexes served to stabilize and 
regulate the availability of the labile chromophores. 
Having observed a lo-fold higher potency for the 
KDC chromoprotein than the KDC chromophore in 
cell-based studies, we compared the activity of purified 
KDC apoprotein, the intact chromoprotein and the 
purified chromophore against DNA and several pro- 
teins in vitro. In contrast to the chromophore and the 
chromoprotein, the apoprotein had no activity against 
DNA. The chromophore, however, did not exhibit any 
cleavage activity against any of the proteins tested, 
whereas the apoprotein and the chromoprotein both 
cleaved proteins selectively. Among the proteins tested, 
histones, the most opposite in net charge to the highly 
acidic apoprotein, were cleaved most readily. Moreover, 
histone Hl, richest in lysines, appeared to be the pre- 
ferred substrate 120,211. Similar activity was noted for 
both MDP and NCS chromoproteins (their corre- 
sponding apoproteins were not tested for availability 
reasons). Histones combine with DNA to form chro- 
matin, the material that makes up chromosomes. Based 
on our results and on chromatin structure, we specu- 
lated that the highly acidic apoproteins may provide 
the chromophores with targeted delivery in vim to the 
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Fig. 1. The protein component of the chromoprotein assists in delivery of the chromophore to DNA. Proposed scheme for the way in 
which the highly acidic apoproteins may provide the chromophores with targeted delivery in vivo to the spacer DNA, by cleaving 
histone HI. The chromophore is shown in green. 
spacer DNA, after cleaving HI (Fig.l).These observa- set of fragments unique to each chromoprotek regardless 
tions, along with the fact that different chromophores of chromoprotein concentration (Fig. 2). 
target different DNA sequences, led us to investigate 
whether these natural proteases exhibit specificity in Incubation of HZ with varying concentrations of the KDC 
their Hl cleavage. apoprotein (10 pg ml-’ to 1 mg m-l) and comparison of 
the resulting cleavage profiles with those obtained using 
Here we show that the chromoproteins described above 
cleave histone Hl to yield a set of fragments unique to 
each chromoprotein used.To probe the specificity exhib- (a) (b) 
ited by the chromoproteins, we synthesized a 24amino- 123456 $23456 7 
acid peptide, representing a particularly basic region of - 
histone Hl 122-281. The peptide was incubated individ- 
ually with similar concentrations of the KDC, NCS and 
MDP chromoproteins as well as the KDC apoprotein. 
The reaction products were then analyzed by electro- - 29 kDa 
spray liquid chromatography/ mass spectrometry 
(LC/MS) [29]. Our results indicate that each chromo- 
protein specifically cleaved the peptide bonds at different 
sites, and that the KDC apoprotein is less specific than 
the KDC chromoprotein complex. - 14.3 kDa 
Results and discussion 
Cleavage of histone Hl by the KDC, NCS and MDP 
chromoproteins and by the KDC apoprotein 
Incubation of Hl with 10 Pg ml-’ (=50:1 molar ratio 
Hl:chromoprotein) of KDC, NCS and MDP chromo- 
proteins results in cleavage profiles that vary according to 
the chromoprotein used as shown by SDS-PAGE (Fig. 2, 
NCS and MDP cleavage patterns shown). At this con- 
centration, MDP produces higher molecular weight frag- 
ments than do NCS and KDC, suggesting that MDP 
may be more selective in its HI cleavage. 
To ensure that the difference in Hl cleavage pattern is 
due to a difference in specificity among the three chro- 
moproteins and not to a difference in activity, Hl was 
incubated with several concentrations of the three chro- 
moproteins, ranging from 10 p,g ml-’ to 1 mg ml-’ .This 
variation in concentration did not alter the above results, 
that is, the three chromoproteins cleaved Hl to yield a 
Fig. 2. SDS-PAGE of the reaction products of (a) NCS and (b) 
MDP with calf thymus histone Hl. Reaction conditions: 
50 mM Tris-HCI (pH 7.5), 1 mg ml-’ Hl and varying concen- 
trations of NCS and MDP in a total volume of 10 ml, 37 “C 
overnight. The control reactions were carried out under identi- 
cal conditions except that the chromoproteins were replaced 
by pure water. Lane 1 : control reactions with HI. Lanes 2, 3, 
4, 5 and 6: reactions of HI with 10 tq ml-‘, 50 )*g ml-‘, 
100 pg ml-‘, 500 wg ml-’ and 1 mg ml-‘, respectively, of 
NCS (a) and MDP (b). Lane 7: protein size standards from 200 
to 14.3 kDa. The band corresponding to NC5 protein seen in 
(a) (lanes 5 and 6) migrates close to the 14.3-kDa marker and 
that corresponding to MDP protein in (b) (lanes 5 and 6) 
migrates close to the 29-kDa marker. 
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Fig. 3. Cleavage of peptide substrate by 
apo/chromoprotein. (a) Peptide 1 with 
numbered residues. The asterisks in (b)-(e) 
indicate the observed cleavage sites 
caused by: (b) KDC apoprotein, (c) KDC 
chromoprotein, (d) NCS and (e) MDP. 
(a) ‘AEKTPVKKKA “AKKPAGAKRK “ASGP-NH, 
(b) AEKTPVKKK*A AKKl’AGAR*R*K*A*SGP-NH 
(c) AEKTPVKKK*A AKKPA*GARRK ASGP-NH, 
(d) AEKTPVKK*K*A AKKPAGARRK* ASGP-NH, 
(e) AEKTPVKKKA AKKPAGARRK* ASGP-NH, 
I 
the KDC chromoprotein suggested a slight difference in 
their cleavage patterns (data not shown). However, the 
observation that at equal concentrations there is a differ- 
ence in activity between the apoKDC and the KDC 
complex (211 makes it difficult to draw conclusions 
about their difference in specificity.The specificity differ- 
ence, however, becomes clearer in the study using the 
peptide as substrate. 
Peptide cleavage by the KDC, NCS and MDP chromoproteins 
LC/MS analyses show that incubation of peptide 1 (Fig. 
3a) with KDC, NCS and MDP chromoproteins at a 
concentration of 10 kg ml-’ results in peptide bond 
cleavage at specific sites. 
The LC/MS results are summarized in Figure 3 and 
Table l.As expected from the Hl study described above, 
the cleavage Fites vary according to the chromoprotein 
used. The KDC chromoprotein cleaves the peptide after 
two major sites, Lys9 and Ala1 5. The points of attack by 
NCS are after LysX, Lys9 and Lys20. MIIP cleaves the 
peptide at one major site, which is after Lys20. These 
cleavage sites resemble those found for proteases in that 
their substrates have common PI sites (nomenclature of 
Schechter and Berger 1301) f or cleavage, specifically ly5ine 
and arginine (trypsin-like). Thus, the proteins appear to 
exhibit a sequence-dependent substrate specificity. 
To ensure that the difference in peptide cleavage is due 
to a difference in specificity among the chromoproteins 
and not to a difference in activity, poptide 1 was incu- 
bated with either 100 pg nil-’ of KIX or 100 pg nil-’ 
of NCS. This lo-fold increase in protein concentration 
did not alter the cleavage data. MDP was not assayed at 
the higher concentration due to lack of material. 
The results obtained in the peptide-cleavage reacrionc 
mirror those observed in the Hl cleavage experiments. 
Each of the protcolytic proteins gives a unique set of 
cleavage products. Although the active-site residues 
i 
Table 1. Cleavage sites of the chromoproteins. 
Chromoprotein 
KDC 
Retention time MW Sequence 
14:45 897.9 16-24 GAKKKASGJ” 
14:51 1028 IL9 AEKJPVKKK 
16:05 1594.6 l-l 5” AEKTPVKKKAAKKPA 
16:20 1464.4 1 O-24” AAKKPACARRKASGP 
17:06 2474.7 l-24” 
Cleavage site 
A%’ 
K*A 
A*G 
K*A 
NCS 4:51 329.2 
1535 1028.1 
16:08 899.7 
16:48 1592.7 
16:52 1464.4 
lb:57 2163.5 
17:31 2475.0 
21-24” ASCP 
l-9 AEKJPVKKK 
IL8 AEKJPVKK 
9-24” KAAKKPAGARRKASGP 
1 O-24” AAKKPAGARRKASGP 
l-20 AEKTPVKKKAAKKPAGARRK 
ord 
2-21 EKTPVKKKAAKKPAGARRKA 
I-24” 
K*A 
K*A 
K*K 
K*K 
K*A 
K*A 
A*& 
- 
MDP 4:45 
16:45 
17:17 
“Unique sequence based on MW. 
329.3 
2163.5 
21-24” ASGP 
l-20 AEKTPVKKKAAKKPAGARRK 
e 
K*A 
K*A 
2-21 EKTPVKKKAikKPAGARRKA A*EyrA*S 
2474.7 l-24” 
hUnderlined portions of sequence were deduced by tandem mass spectrometry. 
‘Asterisk indicates site of cleavage. 
dFor retention time (R.T.) 16:57, there are two possible sequences based on molecular weight; distinction by MS/MS was unsuccess- 
ful. However, since fragment 21-24 at R.T. 4:51 was observed, it is most likely that the fragment at R.T. 16:57 corresponds to l-20. 
%r R.T. 16:45, there exist two possible sequences based on molecular weight; distinction by MS/MS was unsuccessful. However, 
since fragment 21-24 at R.T. 4:45 was observed, it is most likely that the fragment at R.T. 16:45 corresponds to I-20. 
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Table 2. Cleavage sites of the KDC apoprotein. 
Retention Time MW Sequence 
4:56 258.1 22-24” SGP 
5:08 329.1 21-24 ASGP 
5:14 457.4 20-24a KASCP 
15:30 1028.1 l-9 AEKJPVKKKb 
16:47 2163.7 l-20 AEK-JPVKKKAAKKPAGARRK 
16:55 1879.1 l-18a AEKTPVKKKAAKKPACAR 
17:03 2035.1 I-IF AEKTPVKKKAAKKPAGARR 
17124 2474.7 1 -24a 
aUnique sequence based on MW. 
bunderlined portions of sequence were deduced by tandem mass spectrometry. 
CAsterisk indicates site of cleavage. 
Cleavage Site 
A9 
K*A 
R*K 
K*A 
K*A 
R*R 
R*K 
- 
remain to be identified, our results are consistent with 
the low degree of homology shared between the three 
chromoproteins.The amino-acid sequences of KDC and 
NCS share only 38.7 % sequence identity. In addition, 
preliminary data on the amino-acid sequence of MDP 
show that it shares no homology with KDC or NCS 
(H. Marquardt, personal communication). These obser- 
vations suggest that at least some of the amino acids 
involved in the protease active sites are different and 
raise interesting questions regarding the evolutionary 
implications of the different specificities observed. 
Peptide cleavage by the KDC apoprotein 
Incubation of the KDC apoprotein (10 pg ml-l; 9 x 
1O-7 M) with peptide 1 (9 x 1O-4 M) results in several 
major cleavage sites.As can be seen from Figure 3 and 
Table 2, these sites are after the following amino acids: 
Lys9, Arg18, Arg19, Lys20 and Ala21. These results indi- 
cate that the apoprotein cleaves the peptide at more 
sites than its corresponding chromoprotein. This differ- 
ence in proteolytic spec&city between the apo and the 
chromokedarcidin is intriguing. In the absence of 
NMR data and a crystal structure of the KDC chromo- 
protein, it is difficult to offer a definitive interpretation 
of this result. An appealing explanation, however, is that 
the chromophore induces a small conformational 
change on the protein such that the structure of the 
active site of the chromoprotein is slightly different 
from that of the apoprotein. 
Significance 
Many antitumor antibiotics mediate their effects 
by damaging DNA. Often, the efficacy of these 
agents suffers from their poor solubility, low sta- 
bility and inefficient cellular uptake. The enediyne 
chromoproteins seem to have naturally overcome 
these problems, thanks to their apoprotein com- 
ponent. The apoprotein serves multiple purposes: 
it solubilizes the chromophore, shields it from 
deactivation and apparently facilitates its deli+ery 
to the DNA in the nucleus. A more thorough 
understanding of the substrate specificity of these 
proteins and their mechanisms of proteolytic 
activity together with a knowledge of the chemi- 
stry of their corresponding enediyne chro- 
mophores could be invaluable for the design of 
targeted antitumor agents. 
Materials and methods 
Reagents 
KDC chromoprotein and chromophore, MDP and NCS chro- 
moproteins, prepared as described [2,12,21], were kindly pro- 
vided by J.E. Leet, D.R. Schroeder and J. Golik, respectively 
(Division of Chemistry, Bristol-Myers Squibb, Wallingford, 
CT), The 24-amino-acid peptide was synthesized by the solid- 
phase method using Boc/Benzyl chemistry [28]. The chemicals 
and solvents used in peptide synthesis were purchased from 
Applied Biosystems. Calf thymus histone Hl was obtained 
from Boehringer Mannheim. 
Cleavage of histone H 7 by the KDC, NCS and MDP 
chromoproteins and by the KDC apoprotein 
Histone Hl (4 x 10m5 M) was incubated separately with the 
KDC apoprotein, KDC, NCS and MDP chromoproteins 
(IO p,g ml-’ = IO-’ M; 50 p,g ml-‘; 100 kg ml-l; 500 pg ml-‘; 
1 mg ml-‘), in 50 mMTris-HCl buffer at pH 7.5.The incuba- 
tion was carried out at 37 “C overnight at = 50:1 to 0.5:1 
molar ratio in histone: apo/chromoprotein in a total volume of 
10 ~1. The samples were then heated in a denaturing dye for 
one minute and analyzed on a 17 % SDS polyacrylamide gel. 
The protein bands were visualized with Coomassie blue. 
Reaction of the chromoproteins/apoprotein with the 
synthetic peptide 
Peptide 1 (9 x IO-” M) was reacted individually with the 
KDC chromoprotein (10 kgml-’ = 8 x lo-‘M and 
100 kg ml- 1 = 8 x 10e6 M), the NCS chromoprotein 
(IO kg ml-l = 8 x IO-’ M and 100 pg ml-’ = 8 x 1O-6 M), the 
MDP chromoprotein (IO mg ml-’ = 3 x IO-’ M) and the 
apokedarcidin (10 p,g ml-‘; 9 x lo-’ M) in 50 mM Tris-HCl 
buffer at pH 7.5 at 37 “C overnight. 
Purity of the chromoproteins studied 
HPLC analyses and/or visualization by gel-staining with 
Coomassie blue showed single bands corresponding to the 
chromoproteins. Different preparations of the chromopro- 
teins were tested in the histone HI cleavage assay [21] and 
the activity was consistent from batch to batch. As an addi- 
tional check that the proteolytic activity is associated with 
Specific proteolysis by chromoproteins Zein et al. 455 
the chromoprotein, KDC was chromatographed using a size 
exclusion column and fractions were collected throughout 
the entire run. Each fraction was then assayed for Hl cleav- 
age activity [21]. The fraction m which the chromoprotein 
eluted contained essentially all of the activity placed on the 
column (D.W. Phillipson. unpublished results). 
Electrospray liquid chromatography/mass spectrometry 
(LUMS) analyses of the reaction mixtures 
The reaction mixtures were analyzed by LC/MS [29]. All 
LC/MS data was obtained on a Finnigan TSQ700 (San Jose, 
CA) mass spectrometer equipped with a Finnigan electrospray 
source mterfaced to a Water5 600MS gradient HPLC (Millipore 
Corp.. Milford, MA). Chromatographic separations were 
achieved using a 2.0 x 150 mm Partisil Cl8 column (Keystone 
Scientific, Hellefonte, PA) with gradient elution at 0.3 ml min-’ 
A binary linear gradient was formed from 100 o/o to 70 o/o 
mobile phase A in 15 min and then from 70 ‘l/o to 30 o/o A in 
10 min. where mobile phase A was water with 0.05 o/o trifluoro- 
acetic acid and mobile phase B was acetonitrile with 0.05 ‘% tri- 
fluoroacetic acid. Full-scan mass spectra were obtained by 
scanning the mass spectrometer from 250-1250 u in 2 sec. 
Electrospray ionization produces multiply charged ions of the 
type (M+nH)“*, where n is related to the number of basic sites 
on the peptide. In many cases (M+H)+ was not observed. 
Instead, most peptides yield two or more higher charge states, 
such as (M+2H)‘+ and (M+3H)‘+ [29]. Product ion spectra 
were obtained using argon as the collision gas at a pressure of 
2.5-3 mtorr. Collision energiec of 15-25 eV were used. 
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